OSR Health, Inc. — Form 10-Q
Filed August 14, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 8/100
What the filing says
CEO Kuk Hyoun Hwang and CFO Gihyoun Bang signed standard Sarbanes-Oxley certifications on August 14, 2026, for the quarter ended June 30, 2026, attesting to the accuracy of financial statements and effectiveness of disclosure controls. The filing contains no disclosure of material weaknesses, significant deficiencies, or fraud. No specific financial data, transactions, or operational changes are disclosed in these certification exhibits.
Why this rating
Routine mandatory SOX certifications. No disclosure of control weaknesses or fraud is positive but standard. No operational or financial substance disclosed.
See more from August 14, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.